Related Experiment Video
Updated: Jul 20, 2026
Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
The Wnt signaling pathway has tumor suppressor properties in retinoblastoma
Shoshana Tell1, Hyun Yi, Maria-Elena Jockovich
1Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Abstract:
Retinoblastoma is a pediatric retinal tumor caused by mutational inactivation of the tumor suppressor pRb. Additional genetic changes, as yet unidentified, are believed to be required for tumor initiation. Mutations in the Wnt signaling pathway have been implicated in the pathogenesis of many cancers. Multiple Wnt pathway genes are expressed in the retina and the pRb and Wnt pathways interact biochemically, raising the possibility that alterations in the Wnt pathway contribute to retinoblastoma. Our studies showed that Wnt signaling activation significantly decreased the viability of retinoblastoma cell lines by inducing cell cycle arrest, which was associated with upregulated p53. Furthermore, immunolocalization of the Wnt signaling mediator beta-catenin in human and mouse retinoblastoma tissue indicated that canonical Wnt signaling is suppressed in tumors in vivo. These studies are consistent with the Wnt pathway acting as a tumor suppressor in retinoblastoma and suggest that loss of Wnt signaling is tumorigenic in the retina.
Insights
In retinoblastoma, activating the Wnt signaling pathway halts tumor cell growth. This suggests the Wnt pathway acts as a tumor suppressor in the retina, and its loss promotes tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Developmental Biology
Background:
- Retinoblastoma, a pediatric eye cancer, arises from mutations in the tumor suppressor pRb.
- The Wnt signaling pathway is implicated in various cancers, and its genes are present in the retina.
- The interaction between pRb and Wnt pathways suggests a role in retinoblastoma pathogenesis.
Purpose of the Study:
- To investigate the role of Wnt signaling in retinoblastoma.
- To determine if Wnt pathway alterations contribute to retinoblastoma development.
Main Methods:
- Studied the effect of Wnt signaling activation on retinoblastoma cell lines.
- Analyzed p53 expression in response to Wnt activation.
- Used immunolocalization to detect beta-catenin in human and mouse retinoblastoma tissues.
Main Results:
- Wnt signaling activation reduced retinoblastoma cell viability by inducing cell cycle arrest.
- Upregulation of p53 was observed with Wnt signaling activation.
- Canonical Wnt signaling was suppressed in retinoblastoma tumors in vivo, as indicated by beta-catenin localization.
Conclusions:
- The Wnt pathway functions as a tumor suppressor in retinoblastoma.
- Loss of Wnt signaling in the retina promotes tumor formation.
- Targeting Wnt signaling may offer therapeutic strategies for retinoblastoma.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:54Canonical Wnt Signaling Pathway
02:54Canonical Wnt Signaling Pathway
01:41Non-Canonical Wnt Signaling Pathways
01:41Non-Canonical Wnt Signaling Pathways